1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
W. B. & Ellen Gordon Stuart Trust Grants for Texas Heart Disease is sponsored by W.
B. & Ellen Gordon Stuart Trust (administered by JPMorgan). This trust supports health and medical research.
It provides funding to Texas 501(c)(3) organizations studying or treating heart disease. Eligible nonprofits focused on heart disease research, clinical care, or related health initiatives in Texas can apply.
Get alerted about grants like this
Get emailed when new opportunities from “W. B. & Ellen Gordon Stuart Trust (administered by JPMorgan)” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Texas 501(c)(3) organizations studying or treating heart disease. Confirm the full requirements in the official notice before applying.
The current listing shows US $5,000 - US $10,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for W. B. & Ellen Gordon Stuart Trust Grants for Texas Heart Disease are due February 28, 2027. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
W. B. & Ellen Gordon Stuart Trust Grants for Texas Heart Disease is funded by W. B. & Ellen Gordon Stuart Trust (administered by JPMorgan). Verify program details on the funder's official page before applying.
This opportunity targets applicants in Texas. If your organization operates elsewhere, check the official notice for location requirements.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.